MLB: Braves OF Ronald Acuna Jr. (knee) to see specialist

Date:

Share post:


Atlanta Braves star Ronald Acuna Jr. has been diagnosed with irritation around the meniscus in his right knee and will have the injury evaluated further.

An MRI performed Friday showed the condition. He was removed from the lineup in the spring training game against the Baltimore Orioles on Friday as a precaution because of right knee soreness, the team said.

The reigning National League MVP, Acuna will visit Dr. Neal ElAttrache in Los Angeles on Monday for evaluation, per reports. ElAttrache surgically repaired Acuna’s torn right ACL in July 2021.

Acuna was involved in a rundown in Thursday’s game against the Minnesota Twins, and the knee issue apparently occurred during that play.

Acuna, 26, was the NL Rookie of the Year in 2018 and is a four-time All-Star.

In 2023, Acuna became the first 40-70 player in baseball history with 41 home runs and 73 stolen bases, the latter which led the major leagues. He also led the majors in hits (217), runs (149), on-base percentage (.416) and total bases (383).

In 673 career games, Acuna is batting .292 with 767 hits, 161 homers, 402 RBIs and 180 stolen bases.

The Braves signed the outfielder to an eight-year, $100 million deal in 2019.

–Field Level Media

spot_img

Related articles

MLB: LHP Blake Snell agrees to deal with Dodgers

Blake Snell, a two-time Cy Young Award winner, has agreed to sign with the World Series champion Los...

MLB: Rays asked to declare intention on stadium deal by Dec. 1

The Tampa Bay Rays have until Dec. 1 to declare whether they want to commit to the construction...

MLB: Aggressive Angels land LHP Yusei Kikuchi on $63M pact

Left-hander Yusei Kikuchi agreed to a three-year, $63 million deal with the Los Angeles Angels, according to multiple...

MLB: Former All-Star Rico Carty dies at 85

Former top-10 MVP finalist Rico Carty, who played 15 seasons with six different teams, died Saturday in the...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.